Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Omar Abdel-Wahab

2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels

Leukemia and Lymphoma

English

Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy

Advances in Hematology

Hematology

2012

English

Related publications

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

English

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Journal of Clinical Medicine

2017

English

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.

Mediterranean Journal of Hematology and Infectious Diseases

Infectious Diseases

Hematology

2016

English

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

English

Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations

English

Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?

Expert Review of Molecular Diagnostics

English

The Kinetics of Reduction of Minimal Residual Disease Impacts on Duration of Response and Survival of Patients With Acute Myeloid Leukemia

English

Acute Myeloblastic Leukemia With Minimal Myeloid Differentiation: Phenotypical and Ultrastructural Characteristics

English

Genomic 5-Hydroxymethylcytosine Levels Correlate With TET2 Mutations and a Distinct Global Gene Expression Pattern in Secondary Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Omar Abdel-Wahab

2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels

Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy

Related publications

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations

Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?

The Kinetics of Reduction of Minimal Residual Disease Impacts on Duration of Response and Survival of Patients With Acute Myeloid Leukemia

Acute Myeloblastic Leukemia With Minimal Myeloid Differentiation: Phenotypical and Ultrastructural Characteristics

Genomic 5-Hydroxymethylcytosine Levels Correlate With TET2 Mutations and a Distinct Global Gene Expression Pattern in Secondary Acute Myeloid Leukemia